Compare AdaptHealth Corp (AHCO) vs Abercrombie & Fitch Co. (ANF) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Abercrombie & Fitch Co. — how do they compare? AdaptHealth Corp trades at $10.1 (market cap $1.38B), while Abercrombie & Fitch Co. trades at $86.61 (market cap $3.96B). The key difference: Abercrombie & Fitch Co. is far larger — about 2.9× AdaptHealth Corp's market cap. Which is the better fit depends on your goals.
| AHCO | ANF | |
|---|---|---|
Market Cap | $1.38B | $3.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $13.38 | $129.85 |
52-Week Low | $8.68 | $65.61 |
Enterprise Value | $3.33B | $4.63B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
ANF trades at $89.07, down 3.61% today but maintains strong fundamentals with a P/E of 8.68 and robust profitability metrics including 39.04% ROE. The stock shows technical bullish signals with support at $88 and resistance at $92. Recent earnings beats and 2025 revenue growth to $4.95B demonstrate operational strength, while expansion into third-party footwear and Target partnerships highlight growth initiatives.
ANF presents a compelling value opportunity with attractive valuation multiples and consistent earnings outperformance. Key risks include moderating sales growth and international market softness. Analyst consensus price target of $107.71 suggests 21% upside potential, supported by strong institutional sentiment despite near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Abercrombie & Fitch Co.
Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumer through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.
Read more on ANF →
